Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Moderna Inc | 453 |
| 2 | BioNTech SE | 290 |
| 3 | aTyr Pharma Inc | 131 |
| 4 | GSK PLC | 129 |
| 5 | Novartis AG | 92 |
| 6 | University of Pennsylvania | 88 |
| 7 | Thermo Fisher Scientific Inc | 74 |
| 8 | Harvard University | 69 |
| 9 | Wave Life Sciences Pte Ltd | 65 |
| 10 | Revvity Inc | 61 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | C12N | Microorganisms, enzymes | 3,233 |
| 2 | A61K | Medicinal preparations | 3,137 |
| 3 | A61P | Therapeutic activity (drug indications) | 2,664 |
| 4 | C07K | Peptides | 1,505 |
| 5 | C12Q | Measuring/testing involving enzymes | 707 |
| 6 | C12Y | Enzyme nomenclature (EC numbers) | 677 |
| 7 | G01N | Investigating / analysing materials | 598 |
| 8 | C07H | Sugars and derivatives | 451 |
| 9 | Y02A | Climate change adaptation | 405 |
| 10 | C12P | Fermentation, enzyme processes | 259 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| Diagnostic assay for the modified nucleosides pseudouridine, 7-methyladenosine, or 1-methyladenosine | 2001 | 2 |
How research activity has moved
Papers published per year for this compound, over the last decade of indexed records.
| Year | Papers |
|---|---|
| 2016 | 8 |
| 2017 | 10 |
| 2018 | 9 |
| 2019 | 15 |
| 2020 | 8 |
| 2021 | 9 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 8 |
| 2025 | 3 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Michinao Mizugaki | Tohoku University Hospital | 10 |
| 2 | Nakao Ishida | Tohoku University | 8 |
| 3 | Kunihiko Itoh | Tohoku University Hospital | 7 |
| 4 | Qing Dai | University of Chicago | 6 |
| 5 | Tao Pan | University of Chicago | 5 |
| 6 | Chengqi Yi | Peking University | 5 |
| 7 | Shunji Ishiwata | Tohoku University Hospital | 5 |
| 8 | Xushen Xiong | Peking University | 4 |
| 9 | Xiaoyu Li | Peking University | 4 |
| 10 | Mark Helm | Johannes Gutenberg University Mainz | 3 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Post-transcriptional gene regulation by mRNA modifications | 2016 | 2561 | RNA and protein synthesis mechanisms |
| The dynamic N1-methyladenosine methylome in eukaryotic messenger RNA | 2016 | 1066 | RNA and protein synthesis mechanisms |
| Transcriptome-wide mapping reveals reversible and dynamic N1-methyladenosine methylome | 2016 | 717 | Cancer-related molecular mechanisms research |
| The m1A landscape on cytosolic and mitochondrial mRNA at single-base resolution | 2017 | 674 | Cancer-related molecular mechanisms research |
| ALKBH1-Mediated tRNA Demethylation Regulates Translation | 2016 | 602 | Epigenetics and DNA Methylation |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of 1-Methyladenosine?
Which organizations hold the most patents related to 1-Methyladenosine?
What research topics are most frequently associated with 1-Methyladenosine publications?
How has patent activity related to 1-Methyladenosine changed in recent years?
What diagnostic applications have been patented for 1-Methyladenosine?